PUBLIC CONTRACT · 2025
ADALIMUMAB 40 MG/0.4 ML e 80 MG/0.8 ML (Caneta) e RITUximab 100 MG/10 ML e 500MG/50ML AMP IV
- Contract value
- €9,746.04
- Signed on
- 1 September 2025
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11729480PUBLISHED SUBJECT
AQ/1050/2025 - ADALIMUMAB 40 MG/0.4 ML e 80 MG/0.8 ML (Caneta) e RITUximab 100 MG/10 ML e 500MG/50ML AMP IV
Parties involved
- Awardee
- - - CELLTRION PORTUGAL, UNIPESSOAL LDA
- Place of performance
- Portugal, Braga, Guimarães
- NUTS region
- PT119 - Ave
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- - - CELLTRION PORTUGAL, UNIPESSOAL LDA
Values and timeline
- Contract price
- €9,746.04
- Procedure base price
- €105,788.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 19 September 2025
- Award date
- 1 September 2025
- Signing date
- 1 September 2025
- Performance period
- 153 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7859723
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.